loader
Please Wait
Applying Filters...

Information, Expiry & Status of FDA Orange Book Patents covering NCGC00024596-05

Menu
$ API Ref.Price (USD/KG) : 361Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5AVION PHARMS

02 60IMPAX

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

CARBIDOPA; LEVODOPA

US Patent Number : 11819485

Drug Substance Claim :

Drug Product Claim :

Application Number : 214869

Patent Use Code : U-3557

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-03-28

blank

02

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

CARBIDOPA; LEVODOPA

US Patent Number : 11439613

Drug Substance Claim :

Drug Product Claim :

Application Number : 214869

Patent Use Code : U-3557

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-03-28

blank

03

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

CARBIDOPA; LEVODOPA

US Patent Number : 11033521

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214869

Patent Use Code : U-219

Delist Requested :

Patent Use Description : TREATMENT OF PARKINSON...

Patent Expiration Date : 2039-03-28

blank

04

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

CARBIDOPA; LEVODOPA

US Patent Number : 11033521

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214869

Patent Use Code : U-3304

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-03-28

blank

05

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

CARBIDOPA; LEVODOPA

US Patent Number : 11033521

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214869

Patent Use Code : U-3305

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-03-28

blank

06

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

CARBIDOPA; LEVODOPA

US Patent Number : 9089607

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203312

Patent Use Code : U-1645

Delist Requested :

Patent Use Description : TREATMENT OF PARKINSON...

Patent Expiration Date : 2028-12-26

blank

07

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

CARBIDOPA; LEVODOPA

US Patent Number : 9089607

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203312

Patent Use Code : U-1720

Delist Requested :

Patent Use Description : METHOD OF PROVIDING A ...

Patent Expiration Date : 2028-12-26

blank

08

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

CARBIDOPA; LEVODOPA

US Patent Number : 9089607

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203312

Patent Use Code : U-1645

Delist Requested :

Patent Use Description : TREATMENT OF PARKINSON...

Patent Expiration Date : 2028-12-26

blank

09

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

CARBIDOPA; LEVODOPA

US Patent Number : 8377474

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203312

Patent Use Code : U-219

Delist Requested :

Patent Use Description : TREATMENT OF PARKINSON...

Patent Expiration Date : 2028-12-26

blank

10

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

CARBIDOPA; LEVODOPA

US Patent Number : 8377474

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203312

Patent Use Code : U-1645

Delist Requested :

Patent Use Description : TREATMENT OF PARKINSON...

Patent Expiration Date : 2028-12-26

blank